Found 23 matching trials
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
PHASE2The primary purpose of the study is to investigate the effects of high-dose...
Location
H. Lee Moffitt Cancer Center and Research Institute
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
PHASE2This is a Phase II, open-label multicentre, randomised study to assess the ...
Location
Hospices Civils de Lyon
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
N/AAn observational time and motion study in a clinical oncology setting is ut...
Location
The University of Arizona Cancer Center
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
PHASE4The purpose of this study is to assess the efficacy, safety and patient acc...
Location
Westmead Hospital
Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity
PHASE2This study is in patients with at least moderate obesity (Body Mass Index \...
Location
New Orleans Center for Clinical Research
Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
PHASE3The purpose of this study was to evaluate whether everolimus 10 mg / day ad...
Location
University of Arizona / Arizona Cancer Center Deptof Uof A/Arizona Cancer(2)
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
PHASE2To evaluate in combination with corticosteroid and local standard medical c...
Location
Novartis Investigative Site
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
PHASE3RATIONALE: Octreotide may be effective in preventing or controlling diarrhe...
Location
Mobile Infirmary Medical Center
Effects of Sandostatin LAR® in Acromegaly
PHASE4This study aims primarily to determine the effect Insulin-like Growth Facto...
Location
Columbia University Medical Center
177Lu-DOTATATE for Recurrent Meningioma
PHASE2Novel treatments are urgently needed for meningiomas progressing after loca...
Location
A.O Landeskrankenhaus - Innsbruck Universitaetsklinik